Back to GSKView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
1
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Infections, Meningococcal
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Regulatory Approvals
EMA1/13/2013
Bexsero
Active immunisation against invasive disease caused by Neisseria meningitidis serogroup-B strains.
View on EMADrug Science
Mechanism of action & safety profile
Related Pipeline
Combined Hepatitis A and B vaccinePhase 3
Hepatitis B
GSK Biologicals' Meningococcal vaccine GSK134612 (Nimenrix)Phase 3
Infections, Meningococcal
62.5/25mcgPhase 3
Pulmonary Disease, Chronic Obstructive
FluoridePhase 3
Dental Caries
Haemophilus influenzae type b- and meningococcal (vaccine)Phase 3
Haemophilus Influenzae Type b
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts